Skip to content

Integrative Medicine Approach to Neck Wrinkles: A Clinical Study on the Combination of Small Needle Knife Loosening and 1565nm Non-Ablative Fractional Laser

Efficacy of Subcutaneous Loosening Small Needle Knife Combined with 1565nm Non-Ablative Fractional Laser in the Treatment of Neck Wrinkles - CWT: SNK & 1565nm Laser

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400082818
Enrollment
Unknown
Registered
2024-04-09
Start date
2024-04-10
Completion date
Unknown
Last updated
2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cervical Wrinkles

Interventions

Small Needle Knife Treatment Group:The needle insertion point is selected at the neck wrinkles, using the Small Needle Knife produced by Jiangsu Huayou Medical Instruments Co., Ltd. To avoid damaging
Laser Treatment Group:Utilizes 1565nm Non-Ablative Fractional Laser (ResurFX, Lumenis, a medical laser company in the United States). Treatment parameters: For the first pass, a rectangular area is se
Combined Treatment Group: First, complete the subcutaneous separation and loosening of the neck wrinkles using the small needle knife, followed by an overlapping treatment of the neck wrinkles and nec

Sponsors

Dermatology Hospital of Southern Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
25 Years to 60 Years

Inclusion criteria

Inclusion criteria: (1)Ages between 25 and 60 years old. (2)Patients with neck wrinkles who desire treatment. (3)Uniform skin color on the neck without local skin lesions, trauma, or inflammation. (4)Patients who have not received any other cosmetic treatments for the neck within 3 months prior to enrollment. (5)Patients who are able to comply with the study requirements and willing to sign an informed consent form.

Exclusion criteria

Exclusion criteria: (1)Under the age of 25 or over the age of 60. (2)Patients with serious diseases such as neck tumors, inflammation, or infection. (3)Patients with coagulation disorders, blood diseases, immune system diseases, or those on long-term immunosuppressive therapy. (4)Patients with severe chronic diseases such as diabetes, heart disease, liver disease, or kidney disease. (5)Patients with visible skin issues on the neck such as scars, acne, pockmarks, or hyperpigmentation. (6)Patients currently receiving other cosmetic treatments or taking medication that could affect the study results. (7)Patients with thyroid-related diseases such as hyperthyroidism or hypothyroidism, thyroid nodules or tumors, thyroiditis, or autoimmune thyroid disease. (8)Women who are pregnant or planning to become pregnant within the next six months.

Design outcomes

Primary

MeasureTime frame
Measurement of Neck Wrinkle Index Using the Antera 3D Skin Analyzer;

Secondary

MeasureTime frame
Ultrasound measurement of neck dermal thickness and density;Allergan Transverse Neck Lines Scale;Subject satisfaction;Pain index scores and treatment acceptability;Adverse reactions;

Countries

China

Contacts

Public ContactFeiyan Lin

Dermatology Hospital of Southern Medical University

lindachild@163.com+86 186 0892 8120

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026